This text investigates the clinical management, diagnostic criteria, and therapeutic interventions required for patients experiencing febrile neutropenia. Edward B. Rubenstein and Kenneth V. I. Rolston, both established experts in infectious disease and oncology, synthesize clinical data to provide a framework for risk assessment and treatment protocols. The book addresses the complexities of managing immunocompromised patients in hospital settings, focusing on evidence-based strategies to mitigate mortality risks associated with chemotherapy-induced neutropenia.

Medical professionals and oncologists frequently cite this work as a foundational reference for hospital-based infection control. Experts highlight the clinical utility of the text for its structured approach to complex patient management scenarios.